facebook instagram twitter linkedin youtube flickr

All the news

Bluepharma Genéricos was present with its own stand in Expofarma

16.10.2017 in Bluepharma

The event took place at the Lisbon Congress Centre, held from 12 to 14 October


As in previous editions, the Bluepharma Genéricos was present with its own stand in Expofarma, held from 12 to 14 October 2017, at the Lisbon Congress Centre.

Expofarma is the largest pharmaceutical meeting in Portugal. Over the past few years, Expofarma has presented an ever more innovative strategy with very positive results, which translate into more than 6,000 visitors and more than fifty exhibitors.

For Bluepharma, «Expofarma represents a unique opportunity to approach our partners», says Miguel Silvestre.

Bluepharma Genéricos can contact hundreds of pharmacies, publicise its campaigns and present its growing and expanding portfolio – that already includes more than 85 medicinal products.

During the fair, Bluepharma Genéricos had the honour of receiving a visit from the Chairman of the Portuguese Pharmacists' Association, Ana Paula Martins, and the Chairman of the National Association of Pharmacies (ANF), Paulo Cleto Duarte. The event brings together in the Lisbon Congress Centre, the various stakeholders of the pharmaceutical industry, with an extensive programme, which also includes the “National Pharmacists' Congress”, organised by the Portuguese Pharmacists' Association, this year with the theme “Medicinal Products for All”.

At Expofarma, professionals, companies, authorities and other health partners meet to analyse the challenges of the health system in Portugal and to discuss proposals and suggestions for improvement.

During its 16 years of activity, Bluepharma Genéricos has established itself as a brand trusted by all of the industry's stakeholders, pharmacies, users and health professionals for its competitive and reliable and high quality solutions.

Bluepharma Genéricos markets medicines and health products in the main outpatient treatment areas, in the domestic and foreign markets, namely generic medicines with its own brand.